Keith Loria
Keith Loria is a contributing writer to Medical Economics.
Immunotherapy approved for advanced urothelial Ca
Nivolumab (Opdivo) is the second in class of immune checkpoint inhibitors approved for advanced bladder cancer—treatments that are having “tremendous responses across a spectrum of cancers,” says Leonard G. Gomella, MD.
Everything doctors should know about ICD-10 glitch
Everything doctors should know about ICD-10 glitch
CMS has announced a glitch in the quality reporting measures brought upon by the changes in the ICD-CM (Clinical Modification) and ICD-PCS (Procedural Coding System) updates that went into affect Oct. 1.
Apple looks to expand healthcare presence
Apple looks to expand healthcare presence
The tech giant plans to immerse itself more in healthcare in the years ahead
New study supports MET for larger ureteric stones
A recent review of medical literature adds to the debate surrounding medical expulsive therapy for stone disease.
Study examines link between inflammation, prostate Ca
Researchers at UCLA have discovered a previously unrecognized type of progenitor cell in inflamed areas of the prostate that have the ability to initiate cancer in response to genetic changes.
Obamacare rising costs creating challenges for physicians
Obamacare rising costs creating challenges for physicians
With President-Elect Donald Trump having campaigned vowing to repeal Obamacare, there are some who feel that the federal government’s announcement that premiums for midlevel health plans under the Affordable Care Act are expected to increase by an average of 25% in 2017 is nothing to worry about.
Polycythemia risk evaluated in patients on TRT pellets
Researchers evaluated mean hematocrit before and after pellet implantation in a cohort of 97 patients.
Aerobic exercise boosts testosterone levels
Overweight and obese men who participated in 12 weeks of aerobic exercise saw significantly increased testosterone levels, a recent study found.
Persistent decline in renal function seen after first stone case
“Our research shows that the implications of kidney stones may go beyond the discomfort they are so often associated with,” says co-lead author Andrew Rule, MD.
Is 1.5 the new magic number for PSA screening?
A new approach to prostate cancer screening has been proposed by investigators who claim the idea of informed decision-making by primary care physicians is not working when it comes to PSA testing.